Land: Den Europæiske Union
Sprog: engelsk
Kilde: EMA (European Medicines Agency)
amprenavir
Glaxo Group Ltd.
J05AE05
amprenavir
Antivirals for systemic use
HIV Infections
Agenerase, in combination with other antiretroviral agents, is indicated for the treatment of protease inhibitor (PI) experienced HIV-1 infected adults and children above the age of 4 years. Agenerase capsules should normally be administered with low dose ritonavir as a pharmacokinetic enhancer of amprenavir (see sections 4.2 and 4.5). The choice of amprenavir should be based on individual viral resistance testing and treatment history of patients (see section 5.1).The benefit of Agenerase boosted with ritonavir has not been demonstrated in PI nave patients (see section 5.1)
Revision: 18
Withdrawn
2000-10-20
Medicinal product no longer authorised 74 B. PACKAGE LEAFLET Medicinal product no longer authorised 75 PACKAGE LEAFLET : INFORMATION FOR THE USER AGENERASE 50 MG SOFT CAPSULES Amprenavir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1) What Agenerase is and what it is used for 2) Before you take Agenerase 3) How to take Agenerase 4) Possible side effects 5) How to store Agenerase 6) Further information 1. WHAT AGENERASE IS AND WHAT IT IS USED FOR Agenerase belongs to a group of antiviral medicines called protease inhibitors. These medicines are used for treating human immunodeficiency virus (HIV) infection. Agenerase is used in protease inhibitor experienced HIV-1 infected adults and children above the age of 4 years. Agenerase is prescribed for use in combination with other antiretroviral medicinal products. Your doctor will normally direct that Agenerase capsules should be taken with low doses of ritonavir to boost its efficacy. The choice of Agenerase will be based on any resistance testing your doctor may have carried out and your treatment history. The benefit of amprenavir boosted with ritonavir has not been demonstrated in PI naïve patients. 2. BEFORE YOU TAKE AGENERASE DO NOT TAKE AGENERASE - if you are allergic (hypersensitive) to amprenavir or to any of the other ingredients in Agenerase. - if you have severe liver disease (see ‘Take special care with Agenerase’). - you are currently taking any of the following medicines: - astemizole or terfenadine (commonly used to treat allergy symptoms – these medicines may be available without prescription) - pim Læs hele dokumentet
Medicinal product no longer authorised 1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Medicinal product no longer authorised 2 1. NAME OF THE MEDICINAL PRODUCT Agenerase 50 mg soft capsules. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 50 mg of amprenavir. Excipients: d-sorbitol (E420) For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Soft capsule. Oblong, opaque, off-white to cream coloured, printed with ‘GX CC1’. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Agenerase, in combination with other antiretroviral agents, is indicated for the treatment of protease inhibitor (PI) experienced HIV-1 infected adults and children above the age of 4 years. Agenerase capsules should normally be administered with low dose ritonavir as a pharmacokinetic enhancer of amprenavir (see sections 4.2 and 4.5). The choice of amprenavir should be based on individual viral resistance testing and treatment history of patients (see section 5.1). The benefit of Agenerase boosted with ritonavir has not been demonstrated in PI naïve patients (see section 5.1) 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Therapy should be initiated by a physician experienced in the management of HIV infection. The importance of complying with the full recommended dosing regimen should be stressed to all patients. Agenerase is administered orally and can be taken with or without food. Agenerase is also available as an oral solution for use in children or adults unable to swallow capsules. Amprenavir is 14 % less bioavailable from the oral solution than from the capsules; therefore, Agenerase capsules and Agenerase oral solution are not interchangeable on a milligram per milligram basis (see section 5.2). Adults and adolescents of 12 years of age and older (greater than 50 kg body weight): the recommended dose of Agenerase capsules is 600 mg twice daily with ritonavir, 100 mg twice daily, in combination with other antiretroviral agents. If Agenerase capsules are used without the boosting effect of ritonavir high Læs hele dokumentet